Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
Company Blog Articles
April 2, 2020
FDA Green-Lights Clinical Trial For COVID-19 Coronavirus Treatment That ‘Flattens The Curve’ In Patients
Therapeutics startup Celularity announced Thursday morning that it has received FDA clearance to begin a clinical trial of a proposed...
April 2, 2020
Venture-backed Celularity receives FDA approval for early trials of a new cell therapy for COVID-19
Celularity, the venture-backed developer of novel cell therapies for cancer treatments, has received an initial clearance from the Food and...
Dr. Robert Hariri, CEO and founder of Celularity, discusses how the company is exploring a new treatment for COVID-19 as...
The FDA cleared an investigational new drug application for CYNK-001 for the treatment of adults with COVID-19 infection, according to...
Celularity, a New Jersey company developing experimental cancer treatments derived from human placentas, has received the FDA’s blessing to kick...
